Probiotic Bacillus licheniformis to Mitigate Clinical Necrotic Enteritis

reading time
Poster | 09.04.2022
Poster presented by Veerle Hautekiet at ICPIH 2022, Cartagena, Colombia

B-Act, our single strain Bacillus licheniformis probiotic was put to the test to evaluate its ability to improve health and growth performance parameters under a necrotic enteritis (NE) challenge. The results showed that the B-Act treatment group performed as well as the group that received the antibiotic treatment.

Download the poster here

global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us


Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .




North America


South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.


United States

Click here to visit the local website or close this popup to stay on the global website.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now